Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for patients with serious, chronic conditions.

Lexicon is the only company to have systematically studied the role and function of thousands of genes, identifying more than 100 precise protein targets. This precision science is enabling us to pioneer the discovery of innovative, highly targeted medicines that treat serious, chronic conditions safely and effectively, and help patients live better, more empowered lives.

Stock Quote

NASDAQ: LXRX
12.164
-0.406 (-3.230%)
Range 12.160 - 12.568
Open 12.440
Prev Close 12.570
52 Week 11.800 - 19.500
Volume 404698
Market Cap 1.28B
*Delayed 9/26/2017 3:28 EDT

 

Investor and Media Relations Contact

Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000